Dr. Arup Sen

Co-Founder and CEO, Infusion Biosciences

Dr. Sen’s business career started in the biotechnology and biopharmaceutical industry in 1982. He has managed R&D, intellectual property strategy and corporate development (negotiating and managing licenses and joint ventures) with domestic and international companies (J&J, Biomet, GCC and Tokuyama Soda of Japan, Sandoz/Novartis and others). He also has taken three companies from start-up through public trading and has served as the CEO of public and private companies. He received his Ph.D. in biochemistry from Princeton University. His nearly decade long academic career as a faculty member at the National Cancer Institute (Bethesda, Maryland) and at the Scripps Research Institute (La Jolla, California) focused on cancer research.

Dr. Sen has published several dozen papers in top ranking international journals and authored a book on bone diseases. He is an inventor on a number of US patents and numerous international patents and pending patent applications in the fields of cancer therapeutics, bone repair biologics, medical therapeutic devices, and molecular diagnostics.

Matthew Greene

New York, NY, USA
CEO & Founder, Edible Science, LLC

Matt Greene has spent his entire career in the marketing, advertising and AdTech industry. His fascination with technology began in 1987 while working with his client Steve Jobs in developing the launch strategies for NeXT Computers. Starting in 1998, Matt pioneered online advertising and supporting technologies for the digital ad agency he founded, Blue Ribbon Digital, where his team drove innovation across all aspects of digital media - from Search to Mobile and Video, his agency measurably generated over $2BB in revenues for their Fortune 100 clients. In this capacity, Matt has spoken at leading conferences such as AdTech, iMedia Summits and the Googleplex in Mountain View, CA. Starting in 2015, Matt re-focused his energies on the burgeoning cannabis industry knowing that the need for innovation in technologies to support the industry would be mandatory. With his his new company, Edible Sciences, he and his team on concentrating their energies in solving the #1 problem facing the edibles sector: Dosing Accuracy. He will be speaking at Binghampton University's TIER Talks in SEPT '17 on technology innovations occurring in the cannabis ancillary space.
Close

Brett Finkelstein

Boca Raton, FL
Managing Director, Phyto Partners LP

Brett is an experienced executive, venture capital and private equity investor and advisor. He has partnered with, worked with and developed key relationships with numerous premier private equity, investment banks, and venture capital companies. As one of the founders of Phyto Partners LP, Brett’s fundamental ambition for the company’s stakeholders is to creatively apply his unique resources of extensive operating skills, certainty to close, access to capital, extensive network of resources and relentless pursuit of excellence to facilitate a more super-charged evolution for enterprises we fund, launch, and maintain activist roles in. For the powerhouse companies we invest in, advise, and or buy we will be providing more investment value and a comfort level for our financial capital partners, as well as our portfolio companies that join us. Phyto Partners LP was profiled in Forbes as one of the leaders in the cannabis industry. Phyto has invested in half of what CB insights profiled as the trailblazers of 2017. 
Close